Published May 10, 2022
| Version v1
Report
Open
Mass drug administration for malaria burden reduction
- 1. Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
- 2. Rollins School of Public Health, Emory University, Atlanta, United States of America
- 3. U.S. President's Malaria Initiative, Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Description
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.6.1 MDA for burden reduction” of the WHO Guidelines for malaria, 3 June 2022.
Files
Schneider-et-al-2021-mda-for-malaria-burden-reduction.pdf
Files
(2.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6bec4d1fbd427a907699c6583fe01f36
|
2.4 MB | Preview Download |